Lung-sparing Surgery for Malignant Pleural Mesothelioma
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) offers surgery with the potential to enhance longevity for patients with malignant pleural mesothelioma (MPM) and highlights intraoperative strategies to remove microscopic disease.
MPM is a rare disease so patients highly benefit from treatment by a mesothelioma specialist. Joseph S. Friedberg, MD, Charles Reid Edwards Professor of Surgery at the University of Maryland School of Medicine, is a world-leading surgeon in performing pleurectomy/decortication, a procedure that removes the diseased pleura while sparing the patient’s lung. This approach commonly leads to better quality of life and longer survival.
The Maryland Proton Treatment Center (MPTC) is affiliated with UMGCCC. MTPC is the first proton facility on the East Coast to have all of its treatment rooms equipped with pencil beam scanning, a technology that allows radiation oncologists to definitively treat the entire pleural lining with radiotherapy while sparing vital organs. Proton therapy is particularly beneficial for patients with mesothelioma to control their tumor and minimize treatment side effects.
Dr. Friedberg is a member of a comprehensive team of mesothelioma experts in thoracic surgery, medical oncology, radiation oncology, pathology and nursing at UMGCCC’s Mesothelioma and Thoracic Oncology Treatment and Research Center.
To speak with one of our mesothelioma specialists or to refer a patient, call 410-328-6366.